Inclusion of Patient-Reported Outcomes in Adolescent and Young Adult Phase III Therapeutic Trials: An Analysis of Cancer Clinical Trials Registered on ClinicalTrials.gov
Amy M. Berkman(St. Jude Children's Research Hospital), Michael Roth(The University of Texas MD Anderson Cancer Center), Karly M. Murphy(Atrium Health Wake Forest Baptist), John M. Salsman(Atrium Health Wake Forest Baptist), Nancy Lau(Seattle Children's Hospital), Susan K. Parsons(Tufts Medical Center), Yimin Geng(The University of Texas MD Anderson Cancer Center), Elizabeth J. Siembida(Northwell Health)
Cited by 25
Related Papers
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
|Scientific Reports|2016|263
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach
|CA A Cancer Journal for Clinicians|2022|251
Android and iPhone Mobile Apps for Psychosocial Wellness and Stress Management: Systematic Search in App Stores and Literature Review
|JMIR mhealth and uhealth|2020|190